Several reports indicate that the blockade of the IS-aryl hydrocarbon receptor (AhR) signaling pathway may protect endothelial cells from ischemic insult and reduce endothelial dysfunction [45]. The gene discussed is AHR; the disease is endothelial dysfunction.